Next 10 |
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
2024-04-10 06:00:02 ET Richard Felton from Goldman Sachs issued a price target of $100.00 for ALC on 2024-04-10 02:39:00. The adjusted price target was set to $100.00. At the time of the announcement, ALC was trading at $82.68. The overall price target consensus is at $8...
2024-04-09 14:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Alcon welcomes its shareholders to its second in-person AGM In addition to the regular agenda items, shareholders to vote on the Report on Non-Financial Matters Proposed dividend of CHF 0.24 cash per share Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold...
2024-03-20 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $87.64. So far today, approximately 142.97k shares have been exchanged, as compared to an average 30-day volume of 992.37k shares. Alcon Inc., an eye care company, researches, develops, manufactur...
Clareon PCIOLs deliver excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free § IOL material 12-14 Clareon IOLs offer long-lasting clarity backed by extensive real-world experience with excellent outcomes, which is demonstrated in 30 pe...
Vivity is the most implanted extended depth of focus (EDOF) intraocular lens (IOL) globally 1 Milestone underscores the impact of Vivity’s first-of-its-kind, patented wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients 2,3 ...
Q4 2023 sales of $2.3 billion, up 8%, or 10% constant currency (1) (cc) Q4 2023 diluted EPS of $0.86, compared to a loss in the prior year (3) ; core diluted EPS (2) of $0.70 up 67%, or 78% cc FY 2023 sales of $9.4 billion, up 8%, or 10% cc FY 2023 diluted EPS ...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
News, Short Squeeze, Breakout and More Instantly...
2024-04-10 06:00:02 ET Richard Felton from Goldman Sachs issued a price target of $100.00 for ALC on 2024-04-10 02:39:00. The adjusted price target was set to $100.00. At the time of the announcement, ALC was trading at $82.68. The overall price target consensus is at $8...
2024-04-09 14:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Alcon welcomes its shareholders to its second in-person AGM In addition to the regular agenda items, shareholders to vote on the Report on Non-Financial Matters Proposed dividend of CHF 0.24 cash per share Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold...